ADMA BIOLOGICS, INC.
ADMABiological Products, (No Diagnostic Substances) · SIC 2836 · CIK 0001368514
Revenue FY2025
$510.0M
Net Income
$147.0M
EPS (Basic)
$0.62
Net Margin
28.8%
ROE
30.8%
Total Equity
$477.0M
Shares Out
224M
ADMA BIOLOGICS, INC. — Biological Products, (No Diagnostic Substances). Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2011–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 6 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Duquesne Family Office
Stanley Druckenmiller
$23.3M
0.5%
+80.1%
Ashford Capital Management
Ashford Capital Management
$2.8M
0.3%
(6.7%)
Fundsmith
Terry Smith
$13.8M
0.0%
—
Motley Fool Asset Management
Motley Fool Asset Management
$0.8M
0.0%
(9.6%)
Capital Research Global Investors
Capital Research Global Investors
$73.3M
0.0%
(21.8%)
Bridgewater Associates
Bridgewater Associates
$3.4M
0.0%
(15.0%)
Insider Transactions
Reading stored insider transactions…